BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 26753752)

  • 1. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
    In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
    Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer.
    Allen CJ; Vreeland TJ; Newhook TE; Das P; Minsky BD; Blum M; Ajani J; Ikoma N; Mansfield PF; Badgwell BD
    Ann Surg Oncol; 2020 Feb; 27(2):534-542. PubMed ID: 31552618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
    Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
    Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
    Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience.
    Ghidini M; Donida BM; Totaro L; Ratti M; Pizzo C; Benzoni I; Lomiento D; Aldighieri F; Toppo L; Ranieri V; Senti C; Tanzi G; Martinotti M; Passalacqua R; Rovatti M; Tomasello G
    Clin Transl Oncol; 2020 Jul; 22(7):1004-1012. PubMed ID: 31599376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
    Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
    Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
    J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
    Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
    Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
    Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
    Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in patients with gastric cancer. A critical review.
    Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
    Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.